NicoDerm® CQ® and Nicorette®:

Proven Smoking-Cessation Products

Why Nicotine Replacement Therapy Works

Why NRT Works

NRT allows patients to step down their therapeutic nicotine intake as both the physical and behavioral dependence are reduced.1-3 

Replaces

harmful cigarettes

NRT helps manage withdrawal symptoms4

Reduces

dependence on nicotine

NRT allows patients to gradually decrease their therapeutic nicotine intake1,2

Retrains

the urge to smoke 

Cravings are often psychologically motivated and can last for months.

The use of behavioral support programs in conjunction with NRT improves success5-7

More about Nicoderm CQ Patch

NicoDerm® CQ®
PATCH

Helps prevent the urge to smoke all day long8,9 

Features Extended Release Smart Control® Technology that starts to deliver nicotine fast and continues steadily throughout the day.

More about Nicorette Gum

NICORETTE®  GUM

Patented dual-coated technology.* Great taste. Intense craving relief10‡ .

An effective and easily portable solution for craving relief in social situations.

More about Nicorette Lozenge

NICORETTE® LOZENGE

Nicotine lasts even after it dissolves.

Appropriate for patients seeking craving relief that lasts so they can stay focused throughout their journey.

More about Nicorette Mini Lozenge

NICORETTE®  mini LOZENGE

Starts to relieve sudden cravings fast. Anytime. Anywhere11†.

An effective and easily portable solution for craving relief in social situations.

‡Craving relief associated with quitting smoking.
†4 mg only. Craving relief in as little as 3 minutes. Follow label directions for proper dosing.

References:

1. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med.1995;333(18):1196-1203. 2. Tomkins DM, Sellers EM. Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. CMAJ. 2001;164(6):817-821. 3. NicoDerm CQ Clear Patch (GlaxoSmithKline). Drug Reference Encyclopedia website. http://www.theodora.com/drugs/nicoderm_cq_clear_patch_glaxosmithkline.html. Accessed August 25, 2015. 4. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146. 5. Benowitz NL. Cigarette smoking and nicotine addiction. Med Clin North Am. 1992;76(2):415-437. 6. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008. 7. Ashton K, Streem D. Nicotine dependence. Cleveland Clinic, Center for Continuing Education website. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/psychiatry-psychology/smoking-cessation/Default.htm. Accessed August 25, 2015. 8. DeVeaugh-Geiss AM, Chen LH, Kotler ML, Ramsay LR, Durcan MJ. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers. Clin Ther. 2010;32(6):1140-1148. 9. Fant RV, Henningfield JE, Shiffman S, Strahs KR, Reitberg DP. A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches. Pharmacol Biochem Behav. 2000;67(3):479-482. 10. Shiffman S, Shadel WG, Niaura R, et al. Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology (Berl). 2003;166(4):343-350. 11. Data on file, Study S7121359 Topline Survey. GSK. 2012.